This panel brings together leading researchers to explore how health economics can inform policy design in the context of the ...

In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Andrés ...

This is the second in our series of Insights considering the implications of President Trump’s Executive Order on ‘Most ...

As healthcare systems strive to allocate resources efficiently, the use of economic evaluation metrics like Quality-Adjusted ...

In our latest insight, we reflect on what we’re seeing in the region, from Saudi Arabia’s Vision 2030 to the UAE’s push for innovation and value in healthcare.

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return ...

Next-generation sequencing (NGS) generates comprehensive and actionable information on molecular tumour profiles. But despite recommendations for the use of NGS in lung cancer, and support for its ...

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return ...

New antibiotics are urgently needed, but their development is hindered by market failure. A 'volume-delinked model' subscription approach has been suggested to overcome this market failure, providing ...

Background The National Institute for Health and Care Excellence (NICE)’s severity modifier assigns greater weight to health gains to patients with more severe diseases, making it more likely that ...

This report contributes to the understanding of people’s proximity to dementia (e.g., people with dementia and their carers forecast) and so the potential future number of people who will be impacted ...